Daiwa Securities Group Inc. Novo Cure LTD Transaction History

Daiwa Securities Group Inc.

  • $21.6 Billion
  • Q3 2024

A detailed history of Daiwa Securities Group Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 422 shares of NVCR stock, worth $6,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
422
Previous 5,042 91.63%
Holding current value
$6,992
Previous $87,000 91.95%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$15.61 - $23.34 $72,118 - $107,830
-4,620 Reduced 91.63%
422 $7,000
Q2 2024

Aug 07, 2024
SELL
$11.83 - $24.05 $946 - $1,924
-80 Reduced 1.56%
5,042 $87,000
Q1 2024

May 02, 2024
BUY
$12.42 - $17.29 $58,374 - $81,263
4,700 Added 1113.74%
5,122 $80,000
Q3 2023

Nov 01, 2023
SELL
$16.15 - $42.35 $157,720 - $413,590
-9,766 Reduced 95.86%
422 $7,000
Q2 2023

Jul 31, 2023
SELL
$40.29 - $82.51 $49,596 - $101,569
-1,231 Reduced 10.78%
10,188 $423,000
Q1 2023

May 02, 2023
BUY
$56.44 - $118.81 $10,780 - $22,692
191 Added 1.7%
11,419 $686,000
Q4 2022

Feb 06, 2023
SELL
$63.98 - $85.37 $26,551 - $35,428
-415 Reduced 3.56%
11,228 $824,000
Q3 2022

Nov 02, 2022
SELL
$67.99 - $89.57 $18,901 - $24,900
-278 Reduced 2.33%
11,643 $884,000
Q2 2022

Aug 09, 2022
BUY
$56.6 - $89.9 $110,426 - $175,394
1,951 Added 19.57%
11,921 $829,000
Q1 2022

Apr 29, 2022
BUY
$60.15 - $84.52 $119,157 - $167,434
1,981 Added 24.8%
9,970 $826,000
Q4 2021

Feb 03, 2022
BUY
$75.08 - $121.99 $36,563 - $59,409
487 Added 6.49%
7,989 $600,000
Q3 2021

Nov 05, 2021
SELL
$116.17 - $194.55 $219,096 - $366,921
-1,886 Reduced 20.09%
7,502 $871,000
Q2 2021

Aug 06, 2021
SELL
$130.4 - $225.58 $44,336 - $76,697
-340 Reduced 3.5%
9,388 $2.08 Million
Q1 2021

May 03, 2021
BUY
$124.11 - $190.17 $486,014 - $744,705
3,916 Added 67.38%
9,728 $1.29 Million
Q4 2020

Feb 04, 2021
BUY
$112.16 - $174.14 $92,756 - $144,013
827 Added 16.59%
5,812 $1.01 Million
Q3 2020

Nov 02, 2020
BUY
$58.05 - $111.31 $256,929 - $492,658
4,426 Added 791.77%
4,985 $554,000
Q4 2019

Jan 31, 2020
SELL
$68.3 - $93.8 $4,507 - $6,190
-66 Reduced 10.56%
559 $41,000
Q3 2019

Nov 04, 2019
BUY
$61.86 - $97.8 $1,299 - $2,053
21 Added 3.48%
625 $47,000
Q1 2019

Apr 26, 2019
BUY
$31.96 - $56.12 $3,515 - $6,173
110 Added 22.27%
604 $29,000
Q1 2018

May 02, 2018
BUY
$19.3 - $23.65 $9,534 - $11,683
494 New
494 $11,000

Others Institutions Holding NVCR

# of Institutions
260
Shares Held
76.8M
Call Options Held
900K
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.74B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email